AKT1 and nasopharyngeal carcinoma: The data showed that stimulation of glutamatergic differentiation in Wistar NPC did not change the activity of ERK1/2 (Figure 5a) and Akt (Figure 6a) as compared with unstimulated Wistar NPC.